Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-23
1994-04-12
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514245, 514246, 514248, 514249, 514258, 514299, 514300, 514301, 514302, 514303, 544180, 544211, 544212, 544219, 544235, 544236, 544253, 544264, 544278, 544280, 544349, 544350, 546112, 546113, 546114, 546115, 546117, 546118, A61K 31435, A61K 31505, C07D47104, C07D47300
Patent
active
053025962
ABSTRACT:
Novel tricyclic compound represented by formula ##STR1## possess a TXA.sub.2 biosynthesis inhibiting activity and/or a TXA.sub.2 receptor antagonizing activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.
REFERENCES:
patent: 3354155 (1967-11-01), Trette
patent: 3420851 (1969-01-01), Bloom
patent: 4282365 (1981-08-01), Rokach
patent: 4396550 (1983-08-01), Takizawa
patent: 4465835 (1984-08-01), Takizawa
patent: 4585788 (1986-04-01), Helsley
patent: 4596804 (1986-06-01), Takizawa
patent: 4749703 (1988-06-01), Uso
patent: 4882351 (1989-11-01), Oshima
patent: 4994463 (1991-02-01), Oshima
patent: 4999363 (1991-03-01), Oshima
patent: 5010087 (1991-04-01), Oshima
patent: 5010104 (1991-04-01), Oshima
patent: 5118701 (1992-06-01), Oshima
patent: 5143922 (1992-09-01), Oshima
patent: 5242931 (1993-09-01), Oshima et al.
Pinder Drugs, 13, 161-167 (1977).
Tsukada et al., J. Med. Chem., 21 (7) 633-639 (1978).
Uno et al., J. Med. Chem. 19 (7) 941-976 (1976).
Bemesovo, Arz. Forsch., 14, 100-105 (1964).
Melusova, Arz. Forsch., 13, 1039-1045 (1963).
Alluz, J. Med. Chem., 20 (11) 1499-1501 (1977).
Ishii Akio
Karasawa Akira
Kubo Kazuhiro
Miki Ichiro
Obase Hiroyuki
Kyowa Hakko Kogyo Co. Ltd.
Raymond Richard L.
LandOfFree
Tricyclic compounds as TXA.sub.2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds as TXA.sub.2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds as TXA.sub.2 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2098861